rs1055698058

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4

The NM_001301834.1(C12orf57):​c.-16+188G>A variant causes a intron change. The variant allele was found at a frequency of 0.0000502 in 896,030 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000051 ( 1 hom. )

Consequence

C12orf57
NM_001301834.1 intron

Scores

2

Clinical Significance

Likely pathogenic criteria provided, single submitter P:2

Conservation

PhyloP100: 4.70

Publications

0 publications found
Variant links:
Genes affected
C12orf57 (HGNC:29521): (chromosome 12 open reading frame 57) This gene is ubiquitously expressed in human tissues. It is required for development of the human corpus callosum. Mutations in this gene are associated with Temtamy syndrome (TEMTYS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
RNU7-1 (HGNC:34033): (RNA, U7 small nuclear 1) Implicated in Aicardi-Goutieres syndrome. [provided by Alliance of Genome Resources, Apr 2022]
RNU7-1 Gene-Disease associations (from GenCC):
  • Aicardi-Goutieres syndrome 9
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 12-6943850-G-A is Pathogenic according to our data. Variant chr12-6943850-G-A is described in ClinVar as Likely_pathogenic. ClinVar VariationId is 1202615.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001301834.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C12orf57
NM_001301834.1
c.-16+188G>A
intron
N/ANP_001288763.1Q99622
C12orf57
NM_001301836.2
c.13+188G>A
intron
N/ANP_001288765.1
RNU7-1
NR_023317.1
n.35G>A
non_coding_transcript_exon
Exon 1 of 1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
C12orf57
ENST00000544681.1
TSL:2
c.-272G>A
5_prime_UTR
Exon 1 of 2ENSP00000475422.1U3KQ07
C12orf57
ENST00000537087.5
TSL:2
c.-272G>A
5_prime_UTR
Exon 1 of 3ENSP00000440937.1F5GXW5
C12orf57
ENST00000921170.1
c.-272G>A
5_prime_UTR
Exon 1 of 2ENSP00000591229.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152096
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000511
AC:
38
AN:
743816
Hom.:
1
Cov.:
10
AF XY:
0.0000428
AC XY:
16
AN XY:
373414
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
17082
American (AMR)
AF:
0.00
AC:
0
AN:
16492
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13710
East Asian (EAS)
AF:
0.000116
AC:
3
AN:
25942
South Asian (SAS)
AF:
0.0000195
AC:
1
AN:
51380
European-Finnish (FIN)
AF:
0.0000486
AC:
1
AN:
20596
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2468
European-Non Finnish (NFE)
AF:
0.0000533
AC:
30
AN:
562738
Other (OTH)
AF:
0.0000898
AC:
3
AN:
33408
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152214
Hom.:
0
Cov.:
33
AF XY:
0.0000672
AC XY:
5
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41548
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
67980
Other (OTH)
AF:
0.00
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000529

ClinVar

ClinVar submissions
Significance:Likely pathogenic
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Aicardi-Goutieres syndrome 9 (1)
1
-
-
Spasticity (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
15
DANN
Benign
0.76
PhyloP100
4.7
PromoterAI
-0.021
Neutral
RBP_binding_hub_radar
1.1
RBP_regulation_power_radar
2.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1055698058; hg19: chr12-7053013; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.